Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

OBJECTIVE: The primary objective of this study was to evaluate the safety of niraparib 300 mg/day in Japanese patients with platinum-sensitive, relapsed ovarian cancer in a maintenance setting. METHODS: Phase 2, multicenter, open-label, single-arm study enrolled Japanese patients with platinum-sensi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gynecol Oncol
Main Authors: Takehara, Kazuhiro, Matsumoto, Takashi, Hamanishi, Junzo, Hasegawa, Kosei, Matsuura, Motoki, Miura, Kiyonori, Nagao, Shoji, Nakai, Hidekatsu, Tanaka, Naotake, Tokunaga, Hideki, Ushijima, Kimio, Watari, Hidemichi, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Suri, Ajit, Itamochi, Hiroaki, Takeshima, Nobuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930455/
https://ncbi.nlm.nih.gov/pubmed/33470063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados